InsiderTrades.com logo
Download Our Tesla Ebook For Free
From DTI   |   Ad
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
To claim your copy free of charge simply follow this link.

CNTX Insider Trading

Insider Ownership Percentage: 3.04%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Context Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Context Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Context Therapeutics Share Price & Price History

Current Price: $1.50
Price Change: ▼ Price Decrease of -0.13 (-7.98%)
As of 11/21/2024 01:00 AM ET

This chart shows the closing price history over time for CNTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
I've got news for you…
From DTI   |   Ad
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
watch this FREE briefing with me and expert trader Graham Lindman

Context Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/21/2023Martin A. LehrCEOBuy5,823$0.84$4,891.32159,701View SEC Filing Icon  
2/13/2023Martin A. LehrCEOBuy5,606$0.87$4,877.22153,878View SEC Filing Icon  
2/6/2023Martin A. LehrCEOBuy5,040$0.97$4,888.80148,272View SEC Filing Icon  
1/30/2023Martin A. LehrCEOBuy7,027$0.70$4,918.90143,232View SEC Filing Icon  
1/23/2023Martin A. LehrCEOBuy6,839$0.72$4,924.08136,205View SEC Filing Icon  
1/17/2023Martin A. LehrCEOBuy6,783$0.74$5,019.42129,366View SEC Filing Icon  
12/16/2022Jennifer Lynn Minai-AzaryCFOBuy25,000$0.74$18,500.0040,000View SEC Filing Icon  
12/9/2022Alex C. LevitInsiderBuy6,000$0.85$5,100.009,000View SEC Filing Icon  
8/19/2022Martin A. LehrCEOBuy13,000$1.85$24,050.00102,583View SEC Filing Icon  
12/16/2021Martin A. LehrCEOBuy13,000$3.22$41,860.00View SEC Filing Icon  
See Full Table
I've got news for you…
From DTI   |   Ad
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
watch this FREE briefing with me and expert trader Graham Lindman

SEC Filings (Institutional Ownership Changes) for Context Therapeutics (NASDAQ:CNTX)

14.03% of Context Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CNTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Context Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC575,899$1.13M0.0%-6.8%0.768%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd45,635$89K0.0%N/A0.061%Search for SEC Filing on Google Icon
11/15/2024State Street Corp111,907$0.22M0.0%+21.5%0.149%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC1,757,524$3.45M1.8%-6.8%2.343%Search for SEC Filing on Google Icon
11/13/2024Great Point Partners LLC6,934,982$13.59M4.0%-6.5%9.247%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC1,935,484$3.88M0.2%N/A2.581%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC2,258,065$4.53M0.0%N/A3.011%Search for SEC Filing on Google Icon
8/15/2024Blue Owl Capital Holdings LP5,161,290$10.35M2.9%N/A6.882%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC1,619,140$3.25M0.4%+392.4%2.159%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC7,419,355$14.88M2.8%N/A9.893%Search for SEC Filing on Google Icon
8/14/2024Ally Bridge Group NY LLC1,886,232$3.78M2.3%+159.8%2.515%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC65,200$0.13M0.0%+63.4%0.087%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.1,108,357$1.53M0.3%+13.7%1.478%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.975,000$1.10M0.3%N/A6.107%Search for SEC Filing on Google Icon
11/15/2023Affinity Asset Advisors LLC328,817$0.50M0.1%+22.9%2.059%Search for SEC Filing on Google Icon
8/21/2023Affinity Asset Advisors LLC267,574$0.43M0.1%N/A1.675%Search for SEC Filing on Google Icon
7/21/2023Clear Harbor Asset Management LLC36,000$58K0.0%N/A0.225%Search for SEC Filing on Google Icon
2/16/2023AIGH Capital Management LLC1,143,745$0.75M0.2%-11.5%7.162%Search for SEC Filing on Google Icon
2/14/2023swisspartners Ltd.180,000$0.12M0.2%+111.8%1.127%Search for SEC Filing on Google Icon
11/14/2022Worth Venture Partners LLC322,628$0.36M0.2%+8.4%2.021%Search for SEC Filing on Google Icon
11/1/2022swisspartners Ltd.85,000$94K0.1%+101.3%0.532%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC46,445$98K0.0%N/A0.291%Search for SEC Filing on Google Icon
8/12/2022Affinity Asset Advisors LLC883,654$1.87M0.8%+13.6%5.535%Search for SEC Filing on Google Icon
5/4/2022swisspartners Ltd.14,315$4.98M3.5%-66.1%0.090%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP493,531$1.31M0.4%N/A4.501%Search for SEC Filing on Google Icon
2/11/2022QCM Cayman Ltd.14,041$37K0.2%N/A0.128%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC762,721$2.03M0.6%N/A6.955%Search for SEC Filing on Google Icon
2/9/2022swisspartners Ltd.42,235$0.11M0.1%N/A0.385%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Context Therapeutics logo
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Read More on Context Therapeutics

Today's Range

Now: $1.50
Low: $1.32
High: $1.58

50 Day Range

MA: $2.02
Low: $1.63
High: $2.35

52 Week Range

Now: $1.50
Low: $0.77
High: $2.75

Volume

564,764 shs

Average Volume

305,604 shs

Market Capitalization

$112.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.25

Who are the company insiders with the largest holdings of Context Therapeutics?

Context Therapeutics' top insider shareholders include:
  1. Martin A Lehr (CEO)
  2. Jennifer Lynn Minai-Azary (CFO)
  3. Alex C Levit (Insider)
Learn More about top insider investors at Context Therapeutics.

Who are the major institutional investors of Context Therapeutics?

Context Therapeutics' top institutional shareholders include:
  1. Great Point Partners LLC — 9.25%
  2. Ally Bridge Group NY LLC — 2.34%
  3. Geode Capital Management LLC — 0.77%
  4. State Street Corp — 0.15%
  5. Y Intercept Hong Kong Ltd — 0.06%
Learn More about top institutional investors of Context Therapeutics stock.

Which major investors are selling Context Therapeutics stock?

In the last quarter, CNTX stock was sold by these institutional investors:
  1. Great Point Partners LLC
  2. Ally Bridge Group NY LLC
  3. Geode Capital Management LLC

Which major investors are buying Context Therapeutics stock?

Within the last quarter, CNTX stock was purchased by institutional investors including:
  1. Y Intercept Hong Kong Ltd
  2. State Street Corp
During the last year, these company insiders have bought Context Therapeutics stock:
  1. Martin A Lehr (CEO)
  2. Jennifer Lynn Minai-Azary (CFO)
  3. Alex C Levit (Insider)
Learn More investors buying Context Therapeutics stock.
Download Our Tesla Ebook For Free
From DTI   |   Ad
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
To claim your copy free of charge simply follow this link.